Global Market Access Lead Elenestinib - Global Launch Center

​ About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. Join Sanofi’s New Launch Excellence Center in Switzerland – Where Innovation Meets Impact   Sanofi International AG, based in Switzerland, is establishing a new transformational global commercialization center— at the cornerstone of Sanofi "Launch Powerhouse" strategy.  We are building a new world-class, centralized launch engine designed to orchestrate end-to-end commercialization for breakthrough medicines and vaccines across our Immunology and Specialty Care portfolios, that will reinforce and strengthen Sanofi’s existing launch expertise and network. This is not a traditional pharmaceutical role. You will be part of a new pioneering, entrepreneurial entity with real decision-making authority over global launch strategies, pricing corridors, market access, lifecycle management, manufacturing, supply chain, and commercial execution. Working alongside a diverse, cross-functional team of approximately 150 dedicated professionals co-located in Switzerland, you will drive standardized, data-driven, AI-powered launch excellence at unprecedented scale. Why co-location matters : Success in this role requires seamless, daily collaboration across medical affairs, commercial strategy, regulatory, manufacturing & supply, market access, and digital teams. By working together in one location, we eliminate silos, accelerate decision-making, foster innovation through continuous coordination, and create the agility needed to transform patient access worldwide. This is where strategy meets execution—where your work directly impacts millions of patients awaiting our next generation of therapies. About the job The Global Market Access Lead - Elenestinib is a senior individual contributor and strategic leader responsible for developing and executing market access strategies for the pipeline asset Elenestinib, ensuring Elenestinib development addresses remaining unmet needs in the ISM market, delivering best-in-class profile. This role requires deep expertise in reimbursement, health technology assessment (HTA), and pricing frameworks for all major markets, as well as key international markets to help inform the development and ultimate launch of Elenestinib. The Global Market Access Lead - Elenestinib will serve as the primary global market access point of contact for Elenestinib/ISM, partnering closely with local market access teams, global brand teams, medical affairs, HEOR, the GMAx CoE (the Catalyst), and regulatory functions; and coordinating closely with the Ayvakit/SM lead to realize the full pricing/access potential of the ISM portfolio.  Key responsibilities: • Support Health Economics and Values Assessment (HEVA) colleagues with on-going evidence generation activities critical to achieving market access objectives, and will work closely with markets to solicit input today that will help prepare them for future submissions/negotiations. • Key deliverables include MAx materials as needed: market access blueprint, global value story, global pricing policy, contracting strategy (including value-based and outcomes-based frameworks), negotiation guide, objection handler and launch sequencing • Coordinate with HEVA on further execution of budget impact and cost effectiveness model.  ­ • (Once launched: ) Strategic planning for Elenestinib access/pricing maintenance over time, mitigating risks of pricing action by payers and preparing for upcoming competition